focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 75.80
Ask: 76.10
Change: -0.50 (-0.65%)
Spread: 0.30 (0.396%)
Open: 76.70
High: 77.00
Low: 75.90
Prev. Close: 76.50
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Termination of Discussions with RMII

6 Sep 2023 07:00

RNS Number : 4669L
GCP Infrastructure Investments Ltd
06 September 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

6 September 2023

GCP Infrastructure Investments Limited

("GCP Infra" or the "Company")

LEI: 213800W64MNATSIV5Z47

Termination of Discussions with RMII

In the Company's announcement on 11 August 2023, the Board of GCP Infra announced that it was in discussions with the Board of RM Infrastructure Income plc ("RMII") regarding a potential combination (the "RM Scheme").

The Board of GCP Infra has been unable to agree on structure and terms with RMII in respect of the RM Scheme that are acceptable to both parties. GCP Infra has therefore notified RMII of the termination of discussions relating to the RM Scheme.

As per its announcement on 11 August, GCP Infra remains in discussions with the board of GCP Asset Backed Income Fund Limited ("GABI") in respect of a proposed combination of GCP Infra with GABI (the "GABI Scheme"). Heads of Terms have been agreed and a shareholder feedback exercise is being conducted. A circular to shareholders of the Company, providing further details of the Proposals and convening a general meeting to approve the Investment Policy Change, alongside a prospectus, is expected to be published in due course.

For further information please contact:

Gravis Capital Management Limited

Philip Kent

Ed Simpson

Cameron Gardner

 

+44 (0)20 3405 8500

Stifel Nicolaus Europe Limited (Sponsor, Financial Adviser and Broker)

Edward Gibson-Watt

Jonathan Wilkes-Green

Catriona Neville

 

 

+44 (0)20 7710 7600

Buchanan

Helen Tarbet

Henry Wilson

George Beale

 

 

+44 (0)20 7466 5000

Important Information

This announcement contains statements about the Company that are or may be deemed to be forward looking statements. Without limitation, any statements preceded or followed by or that includes the words "targets", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "projects" or words or terms of similar substance of the negative thereof, may be forward looking statements.

 

These forward looking statements are not guarantees of future performance. Such forward looking statements involve known and unknown risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results to differ materially from those projected or implied in any forward looking statement. Due to such uncertainties and risks, readers should not rely on such forward looking statements, which speak only as of the date of this announcement, except as required by applicable law.

 

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities laws of such jurisdictions.

 

Market Abuse Regulation

The information contained within this announcement would have, prior to its release, constituted inside information as stipulated under Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulations 2019 ("UK MAR"). Upon the publication of this announcement via a regulatory information service, this inside information will be considered to be in the public domain.

 

For the purposes of UK MAR, the person responsible for making this announcement is Satty Grewal-Carter, Manager at Apex Financial Services (Alternative Funds) Limited.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSWFMIEDSEDU
Date   Source Headline
28th Apr 20236:11 pmRNSTotal Voting Rights
28th Apr 20235:00 pmRNSTransaction in Own Shares
28th Apr 20234:01 pmRNSChange of Registered Office
27th Apr 20237:00 amRNSNet Asset Value(s)
27th Apr 20237:00 amRNSDividend Declaration
19th Apr 20235:27 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
5th Apr 20235:31 pmRNSTransaction in Own Shares
31st Mar 20235:18 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSDirector Declaration
29th Mar 20235:24 pmRNSTransaction in Own Shares
28th Mar 20234:53 pmRNSTransaction in Own Shares
27th Mar 20234:34 pmRNSTransaction in Own Shares
15th Mar 20235:15 pmRNSTransaction in Own Shares
14th Mar 20235:22 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSShare Buyback Programme Initiated
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Feb 202312:27 pmRNSHolding(s) in Company
15th Feb 202311:42 amRNSResult of AGM
13th Feb 20233:25 pmRNSHolding(s) in Company
7th Feb 20234:52 pmRNSUpdate research from QuotedData
2nd Feb 202310:34 amRNSInvestor Report at 31 December 2022
31st Jan 20233:52 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSNet Asset Value(s)
27th Jan 20237:00 amRNSDividend Declaration
12th Jan 20239:55 amRNSNotice of net asset value announcements
11th Jan 20239:15 amRNSDirector Declaration
9th Jan 20239:15 amRNSNotice of AGM
15th Dec 20227:00 amRNSAnnual report and financial statements
28th Oct 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSInvestor Report at 30 September 2022
26th Oct 20227:00 amRNSDividend Declaration
20th Oct 20227:00 amRNSNet Asset Value(s)
30th Sep 202211:13 amRNSResult of EGM
30th Sep 20227:00 amRNSTotal Voting Rights
13th Sep 20225:21 pmRNSNotice of EGM
6th Sep 20229:18 amRNSAdditional Listing and Total Voting Rights
25th Aug 20229:30 amRNSAdditional Listing
11th Aug 20227:00 amRNSScrip Share Reference Price
29th Jul 20227:00 amRNSInvestor Report at 30 June 2022
27th Jul 202212:37 pmRNSResearch from QuotedData
26th Jul 202210:59 amRNSDividend Declaration & Scrip Dividend Alternative
14th Jul 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:05 amRNSDirectorate Change
21st Jun 20227:00 amRNSHalf-yearly report and financial statements 2022
7th Jun 20229:43 amRNSAdditional Listing and Total Voting Rights
26th May 20229:17 amRNSAdditional Listing
20th May 20223:56 pmRNSHolding(s) in Company
12th May 20227:00 amRNSScrip Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.